Efferon raises €4.3M to expand sepsis hemoadsorption technology into new markets
Efferon raises €4.3M to expand sepsis treatment technology into new markets
Efferon has raised €4.3 million from existing private investors in the DACH region to expand its hemoadsorption devices beyond critical care into healthy aging applications. The funding will support commercial expansion of Efferon LPS and Efferon NEO in Europe, India, and Latin America, plus its 21-distributor network and regulatory work. Efferon devices are used in 46 countries with over 30,000 treatments performed, and the company reported revenue above €1.1 million in 2025.
Source:Tech.eu · tech.eu